Stapleton v. Mylan Specialty LP et al
| Poe Stapleton |
| Mylan Specialty LP, Meridian Medical Technologies, Inc., King Pharmaceuticals, Inc. and Pfizer, Inc. |
| 7:2021cv00057 |
| July 9, 2021 |
| US District Court for the Eastern District of Kentucky |
| David L Bunning |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1441 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 2, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 6
ORDER: re #5 Plf's deadline to respond to Dfts' Motion to Dismiss (DN #4 ) is HELD IN ABEYANCE INDEFINITELY while parties pursue a possible resolution. In event parties reach an impasse and agree to discontinue resolution process, parties shall promptly file a joint status report notifying the Court of discontinuation of resolution process. Plf's time to respond to Motion to Dismiss pursuant to L.R. 7.1 (c) shall begin to run automatically on date of filing of that joint status report. Signed by Judge David L. Bunning on 8/2/2021. (RCB)cc: COR
|
| Filing 5 JOINT MOTION for Extension of Time to File Response/Reply as to #4 MOTION to Dismiss by King Pharmaceuticals, Inc., Meridian Medical Technologies, Inc., Mylan Specialty LP, Pfizer, Inc. by King Pharmaceuticals, Inc., Meridian Medical Technologies, Inc., Mylan Specialty LP, Pfizer, Inc. (Attachments: #1 Proposed Order)(Danford, Daniel) |
| ***MOTION SUBMITTED TO CHAMBERS of Judge Bunning for review: re #5 JOINT MOTION for Extension of Time to File Response as to #4 MOTION to Dismiss. (TDA) |
| Filing 4 MOTION to Dismiss by King Pharmaceuticals, Inc., Meridian Medical Technologies, Inc., Mylan Specialty LP, Pfizer, Inc. (Attachments: #1 Exhibit Ex 1 - FDA Alert, #2 Proposed Order)(Danford, Daniel) |
| Conflict Check run. (TDA) |
| Filing 3 FRCP 7.1 DISCLOSURE STATEMENT by King Pharmaceuticals, Inc., Meridian Medical Technologies, Inc., Mylan Specialty LP, Pfizer, Inc. identifying Mylan Specialty LP. is wholly owned by Mylan Inc., Mylan Inc. is wholly owned by Viatris Inc. (TDA) |
| Filing 1 NOTICE OF REMOVAL from Magoffin Circuit Court, case number 21-CI-00129. (Filing fee $402; receipt number 0643-5014475), filed by Mylan Specialty LP, Meridian Medical Technologies, Inc., King Pharmaceuticals, Inc., Pfizer, Inc. (Attachments: #1 Exhibit A - State Court Record, #2 Exhibit B - 11/20/20 Settlement Demand Letter, #3 Exhibit C - SC Notice of Filing of Removal, #4 Civil Cover Sheet) (TDA) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Kentucky Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
